Victoria Marie Kelly, MD
Rheumatology · Menlo Park
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
Offices
1 location · University Healthcare Alliance · 334 clinicians in this group
Looking this up.
Hospitals listed: Memorial Medical Center · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kelly’s office at (650) 498-6500 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A105305 · Current
Licensed to practise in California · since 2008 · expires 2027-10-31 · University of New Mexico School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Memorial Medical CenterModesto, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.093, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.085, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Memorial Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.093 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.085 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.3 (0.41 to 2.2) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.75 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 185.77 (144.66 to 226.88) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.2 · 237 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 14.1 · 194 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.9 · 513 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.4 · 640 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 278 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 4,882 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.42) · 10,183 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 10,422 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.4 (1.58 to 5.23) · 2,596 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.92 (0.45 to 3.38) · 845 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.1 (1.78 to 4.42) · 2,439 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.71 (5.69 to 17.72) · 885 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.28 (3.75 to 10.81) · 829 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 563 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.2 (0 to 0.72) · 9,080 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 283 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.389 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.485 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.507 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 255 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 849 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 19.2 · 201 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -8.4 · 584 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 26.6 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 895 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.8 (3.3 to 6.9) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (8.4 to 14.3) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 273 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.7 · 108 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 341 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (10.2 to 16.1) · 2,334 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 717 cases | No different | Jan 2024 – Dec 2024 |
What patients said (655 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$183,228
Medicare paid this office $183,228 for 348 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 182 | $58,918 | $158 |
| Return visit (30+ min) | 207 | $40,734 | $114 |
| Injection, denosumab, 1 mg | 16 | $35,780 | None |
| New patient visit (60+ min) | 56 | $10,677 | $191 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 272 | $8,397 | $14 |
See all 17 services
| Long return visit (40+ min) | 182 | $58,918 | $158 |
| Return visit (30+ min) | 207 | $40,734 | $114 |
| Injection, denosumab, 1 mg | 16 | $35,780 | None |
| New patient visit (60+ min) | 56 | $10,677 | $191 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 272 | $8,397 | $14 |
| Aspiration and/or injection of fluid from large joint | 35 | $5,788 | $71 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 14 | $4,016 | $287 |
| Short return visit (20+ min) | 22 | $3,168 | $83 |
| Aspiration and/or injection of fluid from small joint | 25 | $2,052 | $50 |
| Injection into tendon or ligament | 18 | $1,602 | $50 |
| Influenza vaccine split virus, preservative free | 17 | $1,381 | $81 |
| Administration of influenza virus vaccine | 20 | $764 | $38 |
| Aspiration and/or injection of fluid from medium joint | 11 | $663 | $47 |
| Administration of pneumococcal vaccine | 14 | $535 | $38 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 14 | $507 | $28 |
| Injection of drug or substance under skin or into muscle | 16 | $410 | $14 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 74 | $389 | None |
Who their Medicare patients are
348 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 13% · Women 73% · Also on Medicaid 5% · Health risk score 1.46. Above the middle of the specialty; the typical rheumatology clinician is at 1.38.
Conditions among them: High blood pressure 69% · Coronary heart disease 26% · Chronic kidney disease 20% · Diabetes 18% · Cancer 16% · Depression 16% · Atrial fibrillation 15% · Heart failure 14% · COPD 11% · Stroke 5%.
The office billed $750,867, Medicare allowed $239,552 and paid $183,228; for 4,035 services of 31 kinds; $47,199 of it was for drugs given in the office and $136,030 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 348 | 4,035 | 75 | 1.46 | $750,867 | $183,228 |
| 2023 | 354 | 3,385 | 75 | 1.49 | $639,971 | $162,487 |
| 2022 | 373 | 3,501 | 75 | 1.46 | $583,291 | $153,125 |
| 2021 | 311 | 4,892 | 75 | 1.04 | $388,376 | $116,069 |
| 2020 | 280 | 6,780 | 74 | 1.17 | $385,408 | $106,893 |
| 2019 | 308 | 5,882 | 75 | 1.13 | $333,475 | $96,824 |
| 2018 | 334 | 6,345 | 74 | 1.12 | $339,832 | $98,635 |
| 2017 | 358 | 1,444 | 74 | 1.17 | $252,770 | $72,956 |
| 2016 | 307 | 1,674 | 74 | 1.10 | $232,234 | $67,550 |
| 2015 | 213 | 988 | 75 | 1.13 | $184,530 | $55,328 |
| 2014 | 263 | 1,080 | 73 | 1.17 | $218,426 | $65,969 |
| 2013 | 38 | 72 | 72 | 1.38 | $19,544 | $5,679 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Long return visit (40+ min) | 202 | $58,411 | $158 |
| Return visit (30+ min) | 208 | $35,742 | $107 |
| Injection, denosumab, 1 mg | 15 | $31,113 | None |
| New patient visit (60+ min) | 62 | $12,476 | $201 |
| Aspiration and/or injection of fluid from large joint | 37 | $4,961 | $72 |
| Influenza vaccine split virus, preservative free | 44 | $3,162 | $72 |
| Short return visit (20+ min) | 24 | $3,071 | $77 |
| Administration of influenza virus vaccine | 48 | $1,742 | $36 |
| Injection into tendon or ligament | 22 | $1,688 | $43 |
| Aspiration and/or injection of fluid from small joint | 24 | $1,497 | $40 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 17 | $666 | $29 |
| Injection of drug or substance under skin or into muscle | 15 | $386 | $14 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 70 | $337 | None |
2022: 13 services
| Long return visit (40+ min) | 213 | $56,812 | $157 |
| Return visit (30+ min) | 219 | $37,876 | $110 |
| Injection, denosumab, 1 mg | 18 | $27,960 | None |
| Aspiration and/or injection of fluid from large joint | 40 | $4,836 | $71 |
| New patient visit (60+ min) | 19 | $3,882 | $204 |
| Short return visit (20+ min) | 31 | $3,247 | $74 |
| Influenza vaccine split virus, preservative free | 44 | $3,012 | $68 |
| New patient visit (45+ min) | 18 | $2,660 | $148 |
| Injection into tendon or ligament | 24 | $1,707 | $38 |
| Administration of influenza virus vaccine | 46 | $1,683 | $37 |
| Aspiration and/or injection of fluid from small joint | 15 | $969 | $48 |
| Injection of drug or substance under skin or into muscle | 21 | $422 | $14 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 69 | $292 | None |
2021: 13 services
| Return visit (30+ min) | 184 | $36,658 | $118 |
| Long return visit (40+ min) | 79 | $18,093 | $171 |
| New patient visit (45+ min) | 68 | $10,547 | $155 |
| Short return visit (20+ min) | 60 | $6,976 | $84 |
| Aspiration and/or injection of fluid from large joint | 46 | $5,343 | $72 |
| Injection into tendon or ligament | 37 | $3,336 | $44 |
| New patient visit (60+ min) | 12 | $2,342 | $195 |
| Influenza vaccine split virus, preservative free | 29 | $1,893 | $65 |
| New patient visit (30+ min) | 17 | $1,751 | $103 |
| Aspiration and/or injection of fluid from small joint | 25 | $1,322 | $47 |
| Short return visit | 17 | $897 | $53 |
| Administration of influenza virus vaccine | 30 | $648 | $22 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 93 | $356 | None |
2020: 16 services
| Return visit (30+ min) | 151 | $28,359 | $95 |
| New patient visit (45+ min) | 44 | $6,550 | $149 |
| Short return visit (20+ min) | 71 | $6,398 | $65 |
| Long return visit (40+ min) | 32 | $4,788 | $133 |
| Aspiration and/or injection of fluid from large joint | 29 | $3,926 | $65 |
| Injection into tendon or ligament | 36 | $3,056 | $41 |
| Telephone medical discussion with physician, 21-30 minutes | 24 | $3,039 | $105 |
| New patient visit (30+ min) | 24 | $2,008 | $84 |
| Influenza vaccine split virus, preservative free | 28 | $1,707 | $61 |
| Extended patient service without direct patient contact, first hour | 15 | $1,536 | $102 |
| Aspiration and/or injection of fluid from small joint | 19 | $1,204 | $39 |
| Short return visit | 20 | $1,202 | $40 |
| Administration of influenza virus vaccine | 30 | $626 | $21 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 64 | $288 | None |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | 12 | $220 | $15 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 11 | $136 | None |
2019: 14 services
| Return visit (30+ min) | 161 | $28,878 | $93 |
| New patient visit (45+ min) | 46 | $6,807 | $148 |
| Short return visit (20+ min) | 74 | $5,905 | $62 |
| New patient visit (30+ min) | 43 | $3,876 | $90 |
| Long return visit (40+ min) | 25 | $3,855 | $138 |
| Aspiration and/or injection of fluid from large joint | 32 | $2,712 | $52 |
| Injection into tendon or ligament | 28 | $2,007 | $38 |
| Influenza vaccine split virus, preservative free | 29 | $1,608 | $54 |
| Extended patient service without direct patient contact, first hour | 11 | $1,121 | $102 |
| Aspiration and/or injection of fluid from small joint | 21 | $1,016 | $38 |
| Short return visit | 22 | $986 | $32 |
| Administration of influenza virus vaccine | 32 | $676 | $20 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 74 | $236 | None |
| Administration of pneumococcal vaccine | 11 | $225 | $20 |
2018: 12 services
| Return visit (30+ min) | 127 | $25,818 | $90 |
| New patient visit (45+ min) | 63 | $8,910 | $141 |
| Short return visit (20+ min) | 91 | $6,670 | $57 |
| New patient visit (30+ min) | 60 | $5,525 | $92 |
| Long return visit (40+ min) | 29 | $4,475 | $124 |
| Aspiration and/or injection of fluid from large joint | 41 | $3,182 | $58 |
| Injection into tendon or ligament | 33 | $1,826 | $42 |
| Influenza vaccine split virus, preservative free | 26 | $1,177 | $44 |
| Short return visit | 23 | $1,100 | $37 |
| Aspiration and/or injection of fluid from small joint | 25 | $1,058 | $39 |
| Administration of influenza virus vaccine | 32 | $849 | $26 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 96 | $369 | None |
2017: 14 services
| Return visit (30+ min) | 122 | $26,569 | $92 |
| New patient visit (45+ min) | 67 | $9,628 | $144 |
| New patient visit (30+ min) | 84 | $7,997 | $95 |
| Short return visit (20+ min) | 86 | $6,684 | $60 |
| Aspiration and/or injection of fluid from large joint | 58 | $4,234 | $55 |
| Long return visit (40+ min) | 23 | $3,473 | $129 |
| Injection into tendon or ligament | 43 | $2,177 | $43 |
| New patient visit (15+ min) | 30 | $1,814 | $60 |
| Influenza vaccine split virus, preservative free | 35 | $1,537 | $44 |
| Short return visit | 35 | $1,431 | $38 |
| Administration of influenza virus vaccine | 37 | $1,193 | $32 |
| Aspiration and/or injection of fluid from small joint | 21 | $1,000 | $42 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 120 | $641 | None |
| Aspiration and/or injection of fluid from medium joint | 12 | $565 | $47 |
2016: 16 services
| Return visit (30+ min) | 119 | $20,009 | $91 |
| New patient visit (45+ min) | 65 | $9,281 | $143 |
| New patient visit (30+ min) | 75 | $6,827 | $91 |
| Short return visit (20+ min) | 78 | $6,507 | $63 |
| Aspiration and/or injection of fluid from large joint | 65 | $5,024 | $58 |
| Long return visit (40+ min) | 28 | $4,697 | $124 |
| New patient visit (60+ min) | 12 | $2,275 | $190 |
| Injection into tendon or ligament | 24 | $1,801 | $53 |
| Short return visit | 21 | $957 | $42 |
| Influenza vaccine split virus, preservative free | 24 | $871 | $36 |
| Aspiration and/or injection of fluid from small joint | 19 | $824 | $36 |
| Administration of influenza virus vaccine | 26 | $790 | $30 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 97 | $565 | None |
| Aspiration and/or injection of fluid from medium joint | 12 | $561 | $43 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 17 | $98 | None |
| Injection, methylprednisolone acetate, 80 mg | 13 | $90 | None |
2015: 13 services
| Return visit (30+ min) | 113 | $19,335 | $93 |
| Long return visit (40+ min) | 41 | $6,964 | $134 |
| New patient visit (45+ min) | 45 | $6,771 | $150 |
| Aspiration and/or injection of fluid from large joint | 47 | $4,311 | $62 |
| Short return visit (20+ min) | 46 | $4,279 | $68 |
| New patient visit (30+ min) | 30 | $2,944 | $98 |
| New patient visit (60+ min) | 15 | $2,870 | $191 |
| Administration of influenza virus vaccine | 35 | $1,095 | $31 |
| Aspiration and/or injection of fluid from small joint | 15 | $763 | $40 |
| Influenza vaccine split virus, preservative free | 15 | $534 | $36 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 62 | $453 | None |
| Administration of pneumococcal vaccine | 12 | $395 | $30 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 18 | $320 | $18 |
2014: 15 services
| Return visit (30+ min) | 119 | $23,112 | $94 |
| Long return visit (40+ min) | 50 | $9,466 | $128 |
| New patient visit (45+ min) | 53 | $7,396 | $140 |
| Short return visit (20+ min) | 61 | $5,086 | $64 |
| New patient visit (30+ min) | 46 | $4,310 | $94 |
| Aspiration and/or injection of fluid from large joint | 42 | $3,550 | $51 |
| New patient visit (60+ min) | 17 | $3,086 | $182 |
| Pneumococcal vaccine, 13-valent | 15 | $2,241 | $149 |
| Administration of influenza virus vaccine | 28 | $870 | $30 |
| Influenza vaccine split virus, preservative free | 22 | $751 | $33 |
| Aspiration and/or injection of fluid from small joint | 13 | $544 | $42 |
| Aspiration and/or injection of fluid from medium joint | 13 | $524 | $40 |
| Administration of pneumococcal vaccine | 16 | $514 | $30 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 52 | $324 | None |
| Injection, methylprednisolone acetate, 40 mg | 15 | $83 | None |
2013: 1 service
| New patient visit (45+ min) | 11 | $1,591 | $145 |
Drugs they prescribed that Part D paid
$1,802,414
Pharmacies billed $1,802,414 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 9% of their Part D prescriptions (133 of 1,556) in 2024. Above the middle of the specialty; the typical rheumatology clinician is at 3%.
1,265 generic and 280 brand-name prescriptions · $1,802,414 in drug cost · 18 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Humira(Cf) | 41 | $451,864 | $11,021 |
| Humira(Cf) | 21 | $278,634 | $13,268 |
| Enbrel Sureclick | 25 | $179,699 | $7,188 |
| Orencia | 25 | $139,690 | $5,588 |
| Orencia Clickject | 19 | $133,309 | $7,016 |
See all 28 drugs
| Humira(Cf) | 41 | $451,864 | $11,021 |
| Humira(Cf) | 21 | $278,634 | $13,268 |
| Enbrel Sureclick | 25 | $179,699 | $7,188 |
| Orencia | 25 | $139,690 | $5,588 |
| Orencia Clickject | 19 | $133,309 | $7,016 |
| Enbrel | 13 | $95,772 | $7,367 |
| Actemra | 19 | $67,776 | $3,567 |
| Otrexup | 12 | $11,538 | $961 |
| Rasuvo | 15 | $10,057 | $670 |
| Hydroxychloroquine Sulfate | 168 | $7,659 | $46 |
| Methotrexate | 153 | $5,539 | $36 |
| Celecoxib | 55 | $4,529 | $82 |
| Prednisone | 242 | $3,737 | $15 |
| Leflunomide | 38 | $2,674 | $70 |
| Mycophenolate Mofetil | 15 | $2,353 | $157 |
| Hydrocodone-Acetaminophen | 57 | $2,304 | $40 |
| Lidocaine | 18 | $2,004 | $111 |
| Colchicine | 29 | $1,962 | $68 |
| Allopurinol | 68 | $1,521 | $22 |
| Leucovorin | 27 | $1,217 | $45 |
| Sulfasalazine Dr | 11 | $1,153 | $105 |
| Gabapentin | 45 | $868 | $19 |
| Alendronate | 32 | $413 | $13 |
| Tramadol | 45 | $358 | $8 |
| Folic Acid | 24 | $289 | $12 |
| Oxycodone-Acetaminophen | 23 | $189 | $8 |
| Omeprazole | 14 | $130 | $9 |
| Meloxicam | 11 | $67 | $6 |
Year by year
| 2024 | 1,556 | 246 | 9% (133) | 18% | $1,802,414 |
| 2023 | 1,556 | 252 | 9% (132) | None | $1,789,630 |
| 2022 | 1,774 | 361 | 8% (144) | None | $1,496,440 |
| 2021 | 1,882 | 280 | 7% (139) | 9% | $1,014,705 |
| 2020 | 1,661 | 251 | 7% (123) | None | $733,303 |
| 2019 | 1,502 | 232 | 6% (82) | 18% | $595,791 |
| 2018 | 1,735 | 260 | 7% (113) | None | $635,868 |
| 2017 | 1,643 | 236 | 7% (108) | None | $460,262 |
| 2016 | 1,147 | 177 | 7% (78) | 18% | $356,249 |
| 2015 | 946 | 152 | 4% (38) | 27% | $450,169 |
| 2014 | 658 | 132 | 8% (55) | 24% | $181,220 |
| 2013 | 68 | 16 | 24% (16) | None | $4,079 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 26 drugs
| Humira(Cf) | None | 32 | $374,754 | $11,711 |
| Humira(Cf) | None | 18 | $220,160 | $12,231 |
| Enbrel Sureclick | None | 28 | $207,916 | $7,426 |
| Gammagard Liquid | Immune globulin | 20 | $167,588 | $8,379 |
| Enbrel Mini | None | 12 | $98,176 | $8,181 |
| Orencia | None | 14 | $79,256 | $5,661 |
| Actemra Actpen | None | 14 | $60,521 | $4,323 |
| Olumiant | None | 16 | $42,371 | $2,648 |
| Rasuvo | None | 23 | $16,253 | $707 |
| Hydroxychloroquine Sulfate | None | 181 | $12,800 | $71 |
| Methotrexate | None | 123 | $5,597 | $46 |
| Prednisone | None | 282 | $4,068 | $14 |
| Celecoxib | None | 55 | $3,804 | $69 |
| Leflunomide | None | 31 | $3,484 | $112 |
| Mycophenolate Mofetil | None | 14 | $2,790 | $199 |
| Colchicine | None | 34 | $2,473 | $73 |
| Hydrocodone-Acetaminophen | None | 52 | $1,979 | $38 |
| Allopurinol | None | 89 | $1,555 | $17 |
| Leucovorin | None | 17 | $1,285 | $76 |
| Alendronate | None | 35 | $578 | $17 |
| Gabapentin | None | 19 | $357 | $19 |
| Tramadol | None | 52 | $325 | $6 |
| Oxycodone-Acetaminophen | None | 20 | $230 | $12 |
| Cyclobenzaprine | None | 11 | $198 | $18 |
| Folic Acid | None | 44 | $156 | $4 |
| Sulfamethoxazole-Trimethoprim | None | 13 | $30 | $2 |
2022: 31 drugs
| Humira(Cf) | 29 | $279,899 | $9,652 |
| Xeljanz Xr | 38 | $252,208 | $6,637 |
| Enbrel Sureclick | 35 | $237,023 | $6,772 |
| Rinvoq | 17 | $138,530 | $8,149 |
| Orencia | 13 | $70,386 | $5,414 |
| Actemra Actpen | 12 | $34,829 | $2,902 |
| Rasuvo | 25 | $17,955 | $718 |
| Hydroxychloroquine Sulfate | 201 | $16,596 | $83 |
| Methotrexate | 151 | $7,378 | $49 |
| Leflunomide | 42 | $5,743 | $137 |
| Prednisone | 305 | $4,526 | $15 |
| Mycophenolate Mofetil | 25 | $3,546 | $142 |
| Allopurinol | 152 | $3,444 | $23 |
| Celecoxib | 61 | $3,270 | $54 |
| Colchicine | 25 | $2,925 | $117 |
| Febuxostat | 24 | $2,797 | $117 |
| Hydrocodone-Acetaminophen | 59 | $2,057 | $35 |
| Leucovorin | 26 | $1,417 | $54 |
| Gabapentin | 33 | $1,005 | $30 |
| Diclofenac | 27 | $922 | $34 |
| Sulfasalazine | 17 | $790 | $46 |
| Alendronate | 39 | $538 | $14 |
| Omeprazole | 21 | $498 | $24 |
| Valacyclovir | 12 | $255 | $21 |
| Tramadol | 50 | $238 | $5 |
| Folic Acid | 26 | $211 | $8 |
| Ibuprofen | 12 | $160 | $13 |
| Sulfamethoxazole-Trimethoprim | 15 | $153 | $10 |
| Oxycodone-Acetaminophen | 16 | $134 | $8 |
| Famotidine | 11 | $126 | $11 |
| Meloxicam | 13 | $98 | $8 |
2021: 30 drugs
| Xeljanz Xr | 39 | $235,497 | $6,038 |
| Enbrel Sureclick | 26 | $215,545 | $8,290 |
| Humira(Cf) | 12 | $81,065 | $6,755 |
| Actemra | 12 | $54,602 | $4,550 |
| Methotrexate | 223 | $12,649 | $57 |
| Hydroxychloroquine Sulfate | 111 | $12,609 | $114 |
| Colchicine | 61 | $10,049 | $165 |
| Febuxostat | 38 | $4,898 | $129 |
| Prednisone | 309 | $4,733 | $15 |
| Mycophenolate Mofetil | 22 | $4,342 | $197 |
| Celecoxib | 95 | $4,342 | $46 |
| Allopurinol | 183 | $4,246 | $23 |
| Diclofenac | 75 | $1,904 | $25 |
| Probenecid | 12 | $1,692 | $141 |
| Hydrocodone-Acetaminophen | 54 | $1,353 | $25 |
| Gabapentin | 51 | $1,313 | $26 |
| Leucovorin | 40 | $1,156 | $29 |
| Alendronate | 48 | $700 | $15 |
| Omeprazole | 29 | $610 | $21 |
| Tramadol | 42 | $582 | $14 |
| Duloxetine | 16 | $531 | $33 |
| Oxycodone-Acetaminophen | 23 | $290 | $13 |
| Valacyclovir | 11 | $285 | $26 |
| Ibuprofen | 18 | $247 | $14 |
| Sulfamethoxazole-Trimethoprim | 23 | $205 | $9 |
| Methotrexate | 16 | $188 | $12 |
| Acetaminophen-Codeine | 12 | $178 | $15 |
| Folic Acid | 27 | $130 | $5 |
| Meloxicam | 13 | $114 | $9 |
| Carisoprodol | 11 | $51 | $5 |
2020: 30 drugs
| Xeljanz Xr | 29 | $187,565 | $6,468 |
| Enbrel | 17 | $91,562 | $5,386 |
| Enbrel Sureclick | 13 | $90,868 | $6,990 |
| Cosentyx | 13 | $72,955 | $5,612 |
| Hydroxychloroquine Sulfate | 122 | $18,660 | $153 |
| Methotrexate | 204 | $12,160 | $60 |
| Febuxostat | 32 | $9,883 | $309 |
| Colcrys | 17 | $7,390 | $435 |
| Colchicine | 45 | $7,289 | $162 |
| Prednisone | 300 | $4,299 | $14 |
| Mycophenolate Mofetil | 26 | $3,781 | $145 |
| Allopurinol | 149 | $3,441 | $23 |
| Celecoxib | 53 | $3,323 | $63 |
| Diclofenac | 75 | $2,008 | $27 |
| Hydrocodone-Acetaminophen | 61 | $1,623 | $27 |
| Leucovorin | 29 | $1,084 | $37 |
| Azathioprine | 12 | $780 | $65 |
| Gabapentin | 25 | $664 | $27 |
| Valacyclovir | 12 | $567 | $47 |
| Alendronate | 45 | $500 | $11 |
| Tramadol | 33 | $485 | $15 |
| Omeprazole | 17 | $398 | $23 |
| Methotrexate | 14 | $220 | $16 |
| Ibuprofen | 23 | $172 | $7 |
| Meloxicam | 12 | $162 | $14 |
| Sulfamethoxazole-Trimethoprim | 23 | $133 | $6 |
| Oxycodone-Acetaminophen | 14 | $131 | $9 |
| Oxycodone | 12 | $118 | $10 |
| Cyclobenzaprine | 11 | $85 | $8 |
| Carisoprodol | 14 | $44 | $3 |
2019: 27 drugs
| Xeljanz Xr | 33 | $150,657 | $4,565 |
| Enbrel | 21 | $109,707 | $5,224 |
| Enbrel Sureclick | 11 | $54,841 | $4,986 |
| Uloric | 26 | $14,673 | $564 |
| Hydroxychloroquine Sulfate | 84 | $13,412 | $160 |
| Colchicine | 78 | $12,131 | $156 |
| Methotrexate | 186 | $10,589 | $57 |
| Colcrys | 22 | $8,470 | $385 |
| Lyrica | 12 | $6,594 | $549 |
| Febuxostat | 15 | $5,788 | $386 |
| Prednisone | 304 | $4,037 | $13 |
| Mycophenolate Mofetil | 15 | $3,877 | $258 |
| Leflunomide | 13 | $3,349 | $258 |
| Celecoxib | 56 | $3,130 | $56 |
| Allopurinol | 131 | $2,822 | $22 |
| Diclofenac | 63 | $2,107 | $33 |
| Hydrocodone-Acetaminophen | 38 | $1,190 | $31 |
| Leucovorin | 28 | $1,070 | $38 |
| Alendronate | 44 | $565 | $13 |
| Lansoprazole | 11 | $431 | $39 |
| Gabapentin | 28 | $369 | $13 |
| Tramadol | 16 | $311 | $19 |
| Oxycodone-Acetaminophen | 17 | $179 | $11 |
| Omeprazole | 17 | $178 | $10 |
| Amitriptyline | 11 | $177 | $16 |
| Meloxicam | 15 | $129 | $9 |
| Ibuprofen | 13 | $126 | $10 |
2018: 30 drugs
| Xeljanz Xr | 38 | $162,568 | $4,278 |
| Enbrel | 15 | $103,591 | $6,906 |
| Enbrel Sureclick | 14 | $73,178 | $5,227 |
| Uloric | 38 | $20,890 | $550 |
| Cellcept | 12 | $19,336 | $1,611 |
| Hydroxychloroquine Sulfate | 106 | $14,726 | $139 |
| Colchicine | 59 | $14,515 | $246 |
| Mycophenolate Mofetil | 18 | $11,943 | $663 |
| Methotrexate | 183 | $11,866 | $65 |
| Lyrica | 15 | $10,674 | $712 |
| Entecavir | 12 | $10,026 | $835 |
| Celecoxib | 58 | $5,960 | $103 |
| Prednisone | 395 | $5,005 | $13 |
| Colcrys | 17 | $4,199 | $247 |
| Duloxetine | 18 | $2,829 | $157 |
| Hydrocodone-Acetaminophen | 56 | $2,002 | $36 |
| Diclofenac | 50 | $1,856 | $37 |
| Allopurinol | 111 | $1,804 | $16 |
| Leucovorin | 43 | $1,139 | $26 |
| Voltaren | 13 | $1,032 | $79 |
| Gabapentin | 74 | $1,004 | $14 |
| Azathioprine | 11 | $717 | $65 |
| Alendronate | 52 | $440 | $8 |
| Sulfasalazine | 13 | $409 | $31 |
| Oxycodone-Acetaminophen | 22 | $358 | $16 |
| Tramadol | 26 | $246 | $9 |
| Methotrexate | 13 | $216 | $17 |
| Omeprazole | 17 | $209 | $12 |
| Meloxicam | 17 | $137 | $8 |
| Sulfamethoxazole-Trimethoprim | 18 | $82 | $5 |
2017: 26 drugs
| Enbrel | 13 | $94,447 | $7,265 |
| Simponi | 18 | $72,233 | $4,013 |
| Xeljanz Xr | 15 | $57,377 | $3,825 |
| Enbrel Sureclick | 12 | $57,372 | $4,781 |
| Uloric | 48 | $18,273 | $381 |
| Hydroxychloroquine Sulfate | 99 | $15,312 | $155 |
| Methotrexate | 181 | $14,503 | $80 |
| Colchicine | 55 | $14,003 | $255 |
| Lyrica | 17 | $9,278 | $546 |
| Celecoxib | 54 | $6,297 | $117 |
| Prednisone | 411 | $5,490 | $13 |
| Colcrys | 26 | $4,958 | $191 |
| Duloxetine | 25 | $2,718 | $109 |
| Allopurinol | 75 | $1,543 | $21 |
| Diclofenac | 54 | $1,537 | $28 |
| Leucovorin | 44 | $1,451 | $33 |
| Hydrocodone-Acetaminophen | 42 | $935 | $22 |
| Gabapentin | 55 | $845 | $15 |
| Nabumetone | 13 | $599 | $46 |
| Alendronate | 59 | $402 | $7 |
| Tramadol | 38 | $271 | $7 |
| Acetaminophen-Codeine | 13 | $239 | $18 |
| Meloxicam | 24 | $215 | $9 |
| Oxycodone-Acetaminophen | 11 | $190 | $17 |
| Cyclobenzaprine | 11 | $172 | $16 |
| Sulfamethoxazole-Trimethoprim | 19 | $89 | $5 |
2016: 23 drugs
| Enbrel | 17 | $98,459 | $5,792 |
| Simponi | 23 | $86,032 | $3,741 |
| Hydroxychloroquine Sulfate | 55 | $9,910 | $180 |
| Methotrexate | 115 | $7,883 | $69 |
| Uloric | 20 | $6,098 | $305 |
| Colchicine | 26 | $5,938 | $228 |
| Celecoxib | 26 | $4,770 | $183 |
| Prednisone | 292 | $4,379 | $15 |
| Azathioprine | 24 | $1,361 | $57 |
| Duloxetine | 17 | $1,351 | $79 |
| Leucovorin | 39 | $1,325 | $34 |
| Allopurinol | 58 | $1,318 | $23 |
| Mycophenolate Mofetil | 13 | $1,291 | $99 |
| Diclofenac | 32 | $1,074 | $34 |
| Hydrocodone-Acetaminophen | 29 | $1,050 | $36 |
| Fentanyl | 13 | $909 | $70 |
| Voltaren | 11 | $546 | $50 |
| Alendronate | 74 | $532 | $7 |
| Gabapentin | 38 | $436 | $11 |
| Acetaminophen-Codeine | 11 | $205 | $19 |
| Meloxicam | 19 | $172 | $9 |
| Sulfamethoxazole-Trimethoprim | 27 | $145 | $5 |
| Tramadol | 14 | $139 | $10 |
2015: 26 drugs
| Enbrel | 44 | $161,778 | $3,677 |
| Simponi | 19 | $64,112 | $3,374 |
| Humira | 15 | $63,338 | $4,223 |
| Humira | 14 | $51,211 | $3,658 |
| Cimzia | 14 | $43,351 | $3,097 |
| Hydroxychloroquine Sulfate | 62 | $11,115 | $179 |
| Methotrexate | 94 | $7,615 | $81 |
| Uloric | 19 | $5,359 | $282 |
| Lyrica | 11 | $4,923 | $448 |
| Celecoxib | 14 | $3,658 | $261 |
| Prednisone | 189 | $2,563 | $14 |
| Colchicine | 11 | $2,098 | $191 |
| Azathioprine | 22 | $2,026 | $92 |
| Leflunomide | 14 | $1,865 | $133 |
| Voltaren | 32 | $1,743 | $54 |
| Hydrocodone-Acetaminophen | 22 | $596 | $27 |
| Leucovorin | 23 | $564 | $25 |
| Alendronate | 74 | $526 | $7 |
| Allopurinol | 21 | $350 | $17 |
| Diclofenac | 20 | $328 | $16 |
| Omeprazole | 26 | $286 | $11 |
| Gabapentin | 13 | $172 | $13 |
| Meloxicam | 15 | $128 | $9 |
| Pantoprazole | 15 | $116 | $8 |
| Sulfamethoxazole-Trimethoprim | 25 | $89 | $4 |
| Lisinopril | 11 | $18 | $2 |
2014: 17 drugs
| Enbrel | 25 | $69,753 | $2,790 |
| Methotrexate | 58 | $5,122 | $88 |
| Colcrys | 12 | $3,681 | $307 |
| Hydroxychloroquine Sulfate | 37 | $2,883 | $78 |
| Prednisone | 132 | $2,046 | $15 |
| Voltaren | 30 | $1,440 | $48 |
| Leflunomide | 26 | $1,310 | $50 |
| Hydrocodone-Acetaminophen | 30 | $563 | $19 |
| Azathioprine | 14 | $487 | $35 |
| Omeprazole | 26 | $341 | $13 |
| Diclofenac | 12 | $266 | $22 |
| Meloxicam | 19 | $208 | $11 |
| Alendronate | 20 | $169 | $8 |
| Gabapentin | 11 | $116 | $11 |
| Tramadol | 16 | $99 | $6 |
| Isoniazid | 11 | $84 | $8 |
| Sulfamethoxazole-Trimethoprim | 16 | $53 | $3 |
2013: 2 drugs
| Prednisone | 16 | $188 | $12 |
| Hydrocodone-Acetaminophen | 12 | $147 | $12 |
Money from drug and device companies
$61 in 2025
| 2025 | 1 | 4 | None | $61 |
| 2024 | 3 | 5 | None | $220 |
| 2023 | 4 | 8 | None | $196 |
| 2022 | 2 | 4 | None | $73 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novartis Pharmaceuticals | Cosentyx | $61 | 4 payments
|
See all 4 published payments
| Novartis Pharmaceuticals | Meals · 2025-06-26 | Cosentyx | $15 |
| Novartis Pharmaceuticals | Meals · 2025-04-10 | Cosentyx | $14 |
| Novartis Pharmaceuticals | Meals · 2025-03-20 | Cosentyx | $15 |
| Novartis Pharmaceuticals | Meals · 2025-01-10 | Cosentyx | $16 |
See earlier years (2024, 2023, 2022)
2024: $220
| AstraZeneca Pharmaceuticals LP | Saphnelo | $135 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $56 | 3 payments
|
| GlaxoSmithKline | Benlysta | $29 | 1 payment
|
2023: $196
| Janssen Biotech | Tremfya | $114 | 4 payments
|
| Novartis Pharmaceuticals | Cosentyx | $45 | 2 payments
|
| GlaxoSmithKline | Benlysta | $23 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $13 | 1 payment
|
2022: $73
| Janssen Biotech | Tremfya | $54 | 3 payments
|
| GlaxoSmithKline | Benlysta | $19 | 1 payment
|
Professional record
- NPI
- 1366622193
- Licence
- CA A105305California A105305: Current · expires 2027-10-31
- Trained
- University of New Mexico School of Medicine, 2007
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-11-09
- NPI last updated
- 2024-04-25
- NPI record certified
- 2024-04-25
This is when the NPI record was last certified, not a medical board exam.